Stock Details. Get the stock price and latest news for NURO and start trading today with zero commissions. All News News Headlines Press Releases. The beta is 2.79, so NeuroMetrix's price volatility has been higher than the market average. Fiscal Year-end 12/2021. The reporting persons are (i) Topline Capital Management, LLC, an exempt reporting adviser ('Topline'), and (ii) Collin McBirney, Topline's managing member. Each reporting person may be deemed to beneficially own more than 10% of the issuer's outstanding shares of Common Stock. Neurometrix Inc stock is up 101.69% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives NURO stock a score of 23 out of a possible 100.. That rank is mainly influenced by a fundamental score of 0. . Oct 15, 2020 11:00 AM EDT. Get today's NeuroMetrix stock news. You can buy and sell NeuroMetrix (NURO) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Enter Company or Symbol. NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Why NeuroMetrix's Stock is Up During Today's Session NeuroMetrix (NASDAQ: NURO) is currently up 45.17% to a price of $3.04. Revenue $7.38M. In after-market trading hours on Tuesday, NeuroMetrix Inc. (NURO) advanced 7.06% to $3.64. NURO has risen $0.38 from the previous closing price of $2.70 on volume of 682,061 shares. Description: Get the latest NeuroMetrix, Inc. (NURO) stock news and headlines to stay up to date and make informed investing and trading decisions. NeuroMetrix's stock soars in active trade after collaboration with GlaxoSmithKline on Quell Jan. 17, 2018 at 7:25 a.m. 1D 1W 1M 3M 6M 1Y 5Y. Post-Market 0.09 (2.72%) Zacks.com offers in-depth financial research with over 30years of proven results. Phone 1 781 890-9989. NeuroMetrix reports data from Quell trial for treatment of fibromyalgia; shares up 7% SA NewsWed, Jun. Fiscal Year-end 12/2021. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split. Phone 1 781 890-9989. Find real-time NURO - NeuroMetrix Inc stock quotes, company profile, news and forecasts from CNN Business. It can reflect on the current distribution of Neurometrix daily returns and investor perception about the current pice of Neurometrix as well as its diversification or hedging effects on your existing portfolios. About NURO. Press down arrow for suggestions, or Escape to return to entry field. NeuroMetrix Reports Q1 2021 Financial Results. Neurometrix Inc (NURO) stock is higher by 13.92% while the S&P 500 is lower by -0.14% as of 2:37 PM on Tuesday, Dec 22. Therapeutics. Woburn, Massachusetts 01801. GlobeNewswire. NURO: NeuroMetrix, Inc. - Earnings Announcements. NeuroMetrix — $0.00 (0.00%) Today. Sector Health Care/Life Sciences. WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test for evaluation of peripheral neuropathies such as diabetic peripheral neuropathy (DPN). NeuroMetrix Inc. (NASDAQ: NURO) stock closed at 3.12 per share at the end of the most recent trading day (a 1.63 % change compared to the prior day closing price) with a volume of 122.07K shares and market capitalization of 11.87M.Is a component of indices and it is traded on NASDAQ exchange. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. Companies Reporting Before The Bell • Republic First Bancorp (NASDAQ: FRBK ) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million. 09 1 Comment NeuroMetrix, Inc. SEC Filing - … NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Small Market Cap. Stock analysis for NeuroMetrix Inc (NURO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NeuroMetrix sold 7,000 Series E preferred shares (at a price of $1,000 per share) with warrants to purchase approximately 10 million shares of common stock. NeuroMetrix Inc. stock has also gained 3.86% of its value over the past 7 days. DPNCheck® is a point-of-care test that is used to evaluate peripheral neuropathies. View today's stock price, news and analysis for NeuroMetrix Inc. (NURO). No news for in the past two years. Over the past year the S&P 500 is higher by 50.02% while NURO is up 84.13%. As a greater than 10% beneficial owner, the Fund is separately reporting its holdings in the issuer's securities on a Form 3 filed concurrently herewith. NURO is lower by -$0.24 from the previous closing price of $3.72 on volume of 56,956 shares. Still, the Neurometrix earnings-per-share ratio is a good starting point for gauging a company's future prospects . NURO lost -$0.69 per share in the over the last 12 months. Neurometrix story: Purchase by Topline Capital Management Llc of 28238 shares of Neurometrix and other headlines for Neurometrix The Company has three FDA cleared commercial products. This price target is based on 0 analysts offering 12 month price targets for NeuroMetrix in the last 3 months. Our core expertise in biomedical engineering has been refined over two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. Get the latest Neurometrix Inc (NURO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. According to news published on Yahoo Finance, NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020.The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic health conditions. Neurometrix Inc stock is up 101.69% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives NURO stock a score of 23 out of a possible 100.. That rank is mainly influenced by a fundamental score of 0. . Get NeuroMetrix, Inc.'s stock price today. Do NOT follow this link! NeuroMetrix News: This is the News-site for the company NeuroMetrix on Markets Insider NURO's rank also includes a long-term technical score of 26. NeuroMetrix (NURO) said Monday it will secure a new patent for its Quell wearable technology on Tuesday from the US Patent and Trademark Office. News. NURO is higher by $3.55 from the previous closing price of $1.89 on volume of 9,341,946 shares. NeuroMetrix Stock News NASDAQ:NURO. On 22, October 2020, NeuroMetrix Reports Q3 2020 Financial Results. We cover the latest NeuroMetrix headlines and breaking news impacting NeuroMetrix stock performance - Page 2 NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare. NURO Stock Predictions, Articles, and Neurometrix Inc News From the Web NeuroMetrix's Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial Announces Date For Third Quarter 2020 Financial Results Conference Call. NeuroMetrix was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. We cover the latest NeuroMetrix headlines and breaking news impacting NeuroMetrix stock performance. Stay up to date with lastest Earnings Announcements for NeuroMetrix, Inc. from Zacks Investment Research NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. Neurometrix Inc. NURO Stock Message Board: Yes, Topline Capital Partners, 96.5K at $3.42. NURO Neurometrix Inc. Latest News. 10,780,269 titled “Apparatus and Method for Relieving Pain Using Transcutaneous Electrical Nerve Stimulation." Over the past six months meanwhile, it has gained 10.26% and lost -50.00% year-on date. Net Income -$2.09M. This information may help you make smarter investment decisions. NeuroMetrix. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. Investor Relations. We are a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. NeuroMetrix, Inc. Common Stock (NURO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The stock price has increased by +40.38% in the last 52 weeks. Based on an average trading volume of 1,510,000 shares, the days-to-cover ratio is currently 0.0 days. News NeuroMetrix Inc.NURO. Get the latest Neurometrix Inc (NURO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. NURO stock quote, chart and news. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X. NeuroMetrix (NASDAQ: NURO) stock is on the rise Tuesday despite a lack of news concerning the company. NeuroMetrix is a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. 1 stock was originally listed at a price of $92,736.00 in Jul 22, 2004. Neurometrix Inc (NURO) stock is lower by -6.45% while the S&P 500 is up 0.03% as of 1:47 PM on Wednesday, Apr 14. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership ... NeuroMetrix Inc is … WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. Overview Detailed Quote Charting Historical Prices. Neurometrix stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. NeuroMetrix Reports DPNCheck® Expansion in China WOBURN, Mass., July 09, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, … News NeuroMetrix Inc.NURO. Find the latest news headlines from NeuroMetrix, Inc. Common Stock (NURO) at Nasdaq.com. Quote. Get the latest news and real-time alerts from NeuroMetrix, Inc. (NURO) stock at Seeking Alpha. Neurometrix Inc. NURO Vitals Ranked in Earnings Gainer and 1 other category Data delayed 15 minutes The Company will host... NURO : 3.41 (+1.79%) NeuroMetrix Reports Q3 2020 Financial Results GlobeNewswire - Thu Oct … Sector Health Care/Life Sciences. NeuroMetrix's stock reverse split on Friday, May 12th 2017. BRIEF-NeuroMetrix Filed A Prospectus Supplement To Register The Offer And Sale Of $3.85 Million Of Co's Common Stock Reuters – 9:02 AM ET 04/15/2021 As of January 29th, there was short interest totalling 25,900 shares, a decline of 80.4% from the January 14th total of 132,300 shares. WOBURN, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2020. Neurometrix story: Purchase by Topline Capital Management Llc of 28238 shares of Neurometrix and other headlines for Neurometrix Neurometrix stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Neurometrix Inc (NURO) stock has risen 187.83% while the S&P 500 is down -1.01% as of 12:02 PM on Tuesday, Apr 14. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock… NURO has a less variance in analysts' estimates than almost 100% of all US stocks. September 21, 2020 - 1:00 pm. Get Free Stock. 1. News. Find the latest NeuroMetrix, Inc. (NURO) stock quote, history, news and other vital information to help you with your stock trading and investing. Gainers. NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. Embed . NeuroMetrix Inc's average analyst price target is greater than 86.54% of stocks in the small market cap category. The Company is engaged in the sale of medical equipment, and consumables and accessories. NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. PRESS RELEASES. NeuroMetrix, Inc. Revenue $7.38M. News & Events > Stock Details. Over the past year the S&P 500 is … NeuroMetrix, Inc. (NASDAQ:NURO) saw a significant decline in short interest in the month of January. Webull provides the latest NeuroMetrix (NURO) stock and general news. View NeuroMetrix stock trends here About NURO. The Company will host... NURO : 3.41 (+1.79%) NeuroMetrix Reports Q3 2020 Financial Results GlobeNewswire - … Get NeuroMetrix Inc (NURO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. NeuroMetrix (NASDAQ: NURO) stock is on the rise Tuesday despite a lack of news concerning the company. To go along with the increase to NURO stock, the company is seeing heavy trading of its shares. This has more than 57 million shares traded as of this writing. Get today's NeuroMetrix stock news. The company belongs in the Medical Devices & Instruments industry, Healthcare … Industry Medical Equipment/Supplies. NURO. For ETFs and Mutual Funds, return of capital and capital gains distributions are not included. View detailed financial information, real-time news, videos, quotes and analysis on NeuroMetrix, Inc. (NASDAQ:NURO). The upside potential (average analyst target price relative to current price) of NURO is higher than 99.11% of stocks in the small market cap category. WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. NeuroMetrix (NeuroMetrix: NURO) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. NeuroMetrix (NASDAQ:NURO) stock rose 7.05% to $3.64 during Tuesday’s after-market session.Today’s trading volume for this security ended … View the latest NURO stock quote and chart on MSN Money. Neurometrix Inc (NQ: NURO ) 2.920 USD-0.050 (-1.68%) Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2021 Add to My Watchlist. Farm Land For Sale In Danville, Va, What Happens If I Take Hcg And Eat Normally, 50 Euro Cent Coin Value In Pakistani Rupees, Kuttu Ka Atta Other Name, Project Ghoul Kagune Rarity, The Webdriver Photo Printing Service Snapfish Is Owned By, Wegagen Bank Mobile Banking Number, World Scout Moot 2021 Australian Contingent, Tuesday Twitch Streamer, When Tomorrow Starts Without Me Cat, " /> Stock Details. Get the stock price and latest news for NURO and start trading today with zero commissions. All News News Headlines Press Releases. The beta is 2.79, so NeuroMetrix's price volatility has been higher than the market average. Fiscal Year-end 12/2021. The reporting persons are (i) Topline Capital Management, LLC, an exempt reporting adviser ('Topline'), and (ii) Collin McBirney, Topline's managing member. Each reporting person may be deemed to beneficially own more than 10% of the issuer's outstanding shares of Common Stock. Neurometrix Inc stock is up 101.69% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives NURO stock a score of 23 out of a possible 100.. That rank is mainly influenced by a fundamental score of 0. . Oct 15, 2020 11:00 AM EDT. Get today's NeuroMetrix stock news. You can buy and sell NeuroMetrix (NURO) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Enter Company or Symbol. NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Why NeuroMetrix's Stock is Up During Today's Session NeuroMetrix (NASDAQ: NURO) is currently up 45.17% to a price of $3.04. Revenue $7.38M. In after-market trading hours on Tuesday, NeuroMetrix Inc. (NURO) advanced 7.06% to $3.64. NURO has risen $0.38 from the previous closing price of $2.70 on volume of 682,061 shares. Description: Get the latest NeuroMetrix, Inc. (NURO) stock news and headlines to stay up to date and make informed investing and trading decisions. NeuroMetrix's stock soars in active trade after collaboration with GlaxoSmithKline on Quell Jan. 17, 2018 at 7:25 a.m. 1D 1W 1M 3M 6M 1Y 5Y. Post-Market 0.09 (2.72%) Zacks.com offers in-depth financial research with over 30years of proven results. Phone 1 781 890-9989. NeuroMetrix reports data from Quell trial for treatment of fibromyalgia; shares up 7% SA NewsWed, Jun. Fiscal Year-end 12/2021. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split. Phone 1 781 890-9989. Find real-time NURO - NeuroMetrix Inc stock quotes, company profile, news and forecasts from CNN Business. It can reflect on the current distribution of Neurometrix daily returns and investor perception about the current pice of Neurometrix as well as its diversification or hedging effects on your existing portfolios. About NURO. Press down arrow for suggestions, or Escape to return to entry field. NeuroMetrix Reports Q1 2021 Financial Results. Neurometrix Inc (NURO) stock is higher by 13.92% while the S&P 500 is lower by -0.14% as of 2:37 PM on Tuesday, Dec 22. Therapeutics. Woburn, Massachusetts 01801. GlobeNewswire. NURO: NeuroMetrix, Inc. - Earnings Announcements. NeuroMetrix — $0.00 (0.00%) Today. Sector Health Care/Life Sciences. WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test for evaluation of peripheral neuropathies such as diabetic peripheral neuropathy (DPN). NeuroMetrix Inc. (NASDAQ: NURO) stock closed at 3.12 per share at the end of the most recent trading day (a 1.63 % change compared to the prior day closing price) with a volume of 122.07K shares and market capitalization of 11.87M.Is a component of indices and it is traded on NASDAQ exchange. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. Companies Reporting Before The Bell • Republic First Bancorp (NASDAQ: FRBK ) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million. 09 1 Comment NeuroMetrix, Inc. SEC Filing - … NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Small Market Cap. Stock analysis for NeuroMetrix Inc (NURO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NeuroMetrix sold 7,000 Series E preferred shares (at a price of $1,000 per share) with warrants to purchase approximately 10 million shares of common stock. NeuroMetrix Inc. stock has also gained 3.86% of its value over the past 7 days. DPNCheck® is a point-of-care test that is used to evaluate peripheral neuropathies. View today's stock price, news and analysis for NeuroMetrix Inc. (NURO). No news for in the past two years. Over the past year the S&P 500 is higher by 50.02% while NURO is up 84.13%. As a greater than 10% beneficial owner, the Fund is separately reporting its holdings in the issuer's securities on a Form 3 filed concurrently herewith. NURO is lower by -$0.24 from the previous closing price of $3.72 on volume of 56,956 shares. Still, the Neurometrix earnings-per-share ratio is a good starting point for gauging a company's future prospects . NURO lost -$0.69 per share in the over the last 12 months. Neurometrix story: Purchase by Topline Capital Management Llc of 28238 shares of Neurometrix and other headlines for Neurometrix The Company has three FDA cleared commercial products. This price target is based on 0 analysts offering 12 month price targets for NeuroMetrix in the last 3 months. Our core expertise in biomedical engineering has been refined over two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. Get the latest Neurometrix Inc (NURO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. According to news published on Yahoo Finance, NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020.The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic health conditions. Neurometrix Inc stock is up 101.69% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives NURO stock a score of 23 out of a possible 100.. That rank is mainly influenced by a fundamental score of 0. . Get NeuroMetrix, Inc.'s stock price today. Do NOT follow this link! NeuroMetrix News: This is the News-site for the company NeuroMetrix on Markets Insider NURO's rank also includes a long-term technical score of 26. NeuroMetrix (NURO) said Monday it will secure a new patent for its Quell wearable technology on Tuesday from the US Patent and Trademark Office. News. NURO is higher by $3.55 from the previous closing price of $1.89 on volume of 9,341,946 shares. NeuroMetrix Stock News NASDAQ:NURO. On 22, October 2020, NeuroMetrix Reports Q3 2020 Financial Results. We cover the latest NeuroMetrix headlines and breaking news impacting NeuroMetrix stock performance - Page 2 NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare. NURO Stock Predictions, Articles, and Neurometrix Inc News From the Web NeuroMetrix's Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial Announces Date For Third Quarter 2020 Financial Results Conference Call. NeuroMetrix was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. We cover the latest NeuroMetrix headlines and breaking news impacting NeuroMetrix stock performance. Stay up to date with lastest Earnings Announcements for NeuroMetrix, Inc. from Zacks Investment Research NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. Neurometrix Inc. NURO Stock Message Board: Yes, Topline Capital Partners, 96.5K at $3.42. NURO Neurometrix Inc. Latest News. 10,780,269 titled “Apparatus and Method for Relieving Pain Using Transcutaneous Electrical Nerve Stimulation." Over the past six months meanwhile, it has gained 10.26% and lost -50.00% year-on date. Net Income -$2.09M. This information may help you make smarter investment decisions. NeuroMetrix. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. Investor Relations. We are a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. NeuroMetrix, Inc. Common Stock (NURO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The stock price has increased by +40.38% in the last 52 weeks. Based on an average trading volume of 1,510,000 shares, the days-to-cover ratio is currently 0.0 days. News NeuroMetrix Inc.NURO. Get the latest Neurometrix Inc (NURO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. NURO stock quote, chart and news. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X. NeuroMetrix (NASDAQ: NURO) stock is on the rise Tuesday despite a lack of news concerning the company. NeuroMetrix is a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. 1 stock was originally listed at a price of $92,736.00 in Jul 22, 2004. Neurometrix Inc (NURO) stock is lower by -6.45% while the S&P 500 is up 0.03% as of 1:47 PM on Wednesday, Apr 14. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership ... NeuroMetrix Inc is … WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. Overview Detailed Quote Charting Historical Prices. Neurometrix stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. NeuroMetrix Reports DPNCheck® Expansion in China WOBURN, Mass., July 09, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, … News NeuroMetrix Inc.NURO. Find the latest news headlines from NeuroMetrix, Inc. Common Stock (NURO) at Nasdaq.com. Quote. Get the latest news and real-time alerts from NeuroMetrix, Inc. (NURO) stock at Seeking Alpha. Neurometrix Inc. NURO Vitals Ranked in Earnings Gainer and 1 other category Data delayed 15 minutes The Company will host... NURO : 3.41 (+1.79%) NeuroMetrix Reports Q3 2020 Financial Results GlobeNewswire - Thu Oct … Sector Health Care/Life Sciences. NeuroMetrix's stock reverse split on Friday, May 12th 2017. BRIEF-NeuroMetrix Filed A Prospectus Supplement To Register The Offer And Sale Of $3.85 Million Of Co's Common Stock Reuters – 9:02 AM ET 04/15/2021 As of January 29th, there was short interest totalling 25,900 shares, a decline of 80.4% from the January 14th total of 132,300 shares. WOBURN, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2020. Neurometrix story: Purchase by Topline Capital Management Llc of 28238 shares of Neurometrix and other headlines for Neurometrix Neurometrix stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Neurometrix Inc (NURO) stock has risen 187.83% while the S&P 500 is down -1.01% as of 12:02 PM on Tuesday, Apr 14. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock… NURO has a less variance in analysts' estimates than almost 100% of all US stocks. September 21, 2020 - 1:00 pm. Get Free Stock. 1. News. Find the latest NeuroMetrix, Inc. (NURO) stock quote, history, news and other vital information to help you with your stock trading and investing. Gainers. NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. Embed . NeuroMetrix Inc's average analyst price target is greater than 86.54% of stocks in the small market cap category. The Company is engaged in the sale of medical equipment, and consumables and accessories. NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. PRESS RELEASES. NeuroMetrix, Inc. Revenue $7.38M. News & Events > Stock Details. Over the past year the S&P 500 is … NeuroMetrix, Inc. (NASDAQ:NURO) saw a significant decline in short interest in the month of January. Webull provides the latest NeuroMetrix (NURO) stock and general news. View NeuroMetrix stock trends here About NURO. The Company will host... NURO : 3.41 (+1.79%) NeuroMetrix Reports Q3 2020 Financial Results GlobeNewswire - … Get NeuroMetrix Inc (NURO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. NeuroMetrix (NASDAQ: NURO) stock is on the rise Tuesday despite a lack of news concerning the company. To go along with the increase to NURO stock, the company is seeing heavy trading of its shares. This has more than 57 million shares traded as of this writing. Get today's NeuroMetrix stock news. The company belongs in the Medical Devices & Instruments industry, Healthcare … Industry Medical Equipment/Supplies. NURO. For ETFs and Mutual Funds, return of capital and capital gains distributions are not included. View detailed financial information, real-time news, videos, quotes and analysis on NeuroMetrix, Inc. (NASDAQ:NURO). The upside potential (average analyst target price relative to current price) of NURO is higher than 99.11% of stocks in the small market cap category. WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. NeuroMetrix (NeuroMetrix: NURO) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. NeuroMetrix (NASDAQ:NURO) stock rose 7.05% to $3.64 during Tuesday’s after-market session.Today’s trading volume for this security ended … View the latest NURO stock quote and chart on MSN Money. Neurometrix Inc (NQ: NURO ) 2.920 USD-0.050 (-1.68%) Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2021 Add to My Watchlist. Farm Land For Sale In Danville, Va, What Happens If I Take Hcg And Eat Normally, 50 Euro Cent Coin Value In Pakistani Rupees, Kuttu Ka Atta Other Name, Project Ghoul Kagune Rarity, The Webdriver Photo Printing Service Snapfish Is Owned By, Wegagen Bank Mobile Banking Number, World Scout Moot 2021 Australian Contingent, Tuesday Twitch Streamer, When Tomorrow Starts Without Me Cat, " />

neurometrix stock news

Av - 14 juni, 2021

Enter Company or Symbol. The Company is … Stock analysis for NeuroMetrix Inc (NURO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Neurometrix Inc. A range of $3.355 to $3.75 was the price range of the NURO stock. Looking to buy NeuroMetrix stock? After losing roughly half of its value on Monday, when news of the AMA recommendation first surfaced, NeuroMetrix's stock tumbled another 22% to $4.20 Tuesday. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. 6 months ago - Benzinga WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. NeuroMetrix (NURO) stock is on the rise Tuesday with heavy trading despite a lack of news concerning the medical device company. Net Income … 542,240 shares of Common Stock reported in Table I on this Form 3 are beneficially owned by Topline Capital Partners, LP, Delaware limited partnership (the "Fund"). Pain Control. NURO's rank also includes a long-term technical score of 26. Overview Detailed Quote Charting Historical Prices. If you had invested in NeuroMetrix stock at $92,736.00, your return over the last 16 years would have been -100%, for an annualized return of -47.27%. The stock's volume is currently 62.04 million, which is roughly 32668.92% of its recent 30-day volume average of 189.91 thousand. WOBURN, Mass., July 09, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction. Woburn, Massachusetts 01801. No news for in the past two years. In depth view into NURO (NeuroMetrix) stock including the latest price, news, dividend history, earnings information and financials. The 1-8 reverse split was announced on Thursday, May 11th 2017. The Company is engaged in the sale of medical equipment, and consumables and accessories. Quote. The average price target represents a -100.00% upside from the last price of $4.83. NeuroMetrix Inc. NASDAQ Updated Jun 11, 2021 11:56 PM NURO 3.31 0.03 (0.90%). Find real-time NURO - NeuroMetrix Inc stock quotes, company profile, news and forecasts from CNN Business. Customizable interactive chart for Neurometrix Inc with latest real-time price quote, charts, latest news, technical analysis and opinions. All News for NURO : NeuroMetrix, Inc. - Zacks.com Press down arrow for suggestions, or Escape to return to entry field. The Company is a leader in proprietary non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Get news for Nasdaq companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public. View detailed financial information, real-time news, videos, quotes and analysis on NeuroMetrix, Inc. (NASDAQ:NURO). Stock Price Statistics. All News News Headlines Press Releases. NeuroMetrix to Secure New US Patent for Quell Wearable Technology 5:21PM ET 9/21/2020 MT Newswires. However, NURO stock has inclined by 34.38% in the 3 months of the year. NeuroMetrix Reports DPNCheck® Expansion in China. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. 2. Announces Date for Fourth Quarter and Full Year 2020 Financial Results Conference Call - GlobeNewswire globenewswire.com - … Industry Medical Equipment/Supplies. NURO Stock Price, NeuroMetrix Stock Quotes and News - Benzinga quotes.benzinga.com - January 26 at 5:23 PM: NeuroMetrix, Inc. Earnings Scheduled For April 22, 2021 08:01am, Thursday, 22'nd Apr 2021. Over the past year the S&P 500 has fallen -4.95% while NURO is down … Estimates are provided for securities with at least 5 consecutive payouts, special dividends not included. Neurometrix Inc (NQ: NURO ) 2.920 USD-0.050 (-1.68%) Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2021 Add to My Watchlist. WOBURN, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 first quarter financial results before the opening of the market on Apr... NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q4 2020 Results - Earnings Call Transcript NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. Dive deeper with interactive charts and top stories of NEUROMETRIX, INC.. ... Neurometrix Inc. U.S. News & World Report 5/19/2021. WOBURN, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office will issue on September 22, 2020 U.S. Patent No. Our core expertise in biomedical engineering has been refined over two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. Looking for stock market analysis and research with proves results? During the last trading session, NeuroMetrix stock gained 0.29% to close at $3.40. By GlobeNewswire. If the last five payouts show limited variability, we … News & Events > Stock Details. Get the stock price and latest news for NURO and start trading today with zero commissions. All News News Headlines Press Releases. The beta is 2.79, so NeuroMetrix's price volatility has been higher than the market average. Fiscal Year-end 12/2021. The reporting persons are (i) Topline Capital Management, LLC, an exempt reporting adviser ('Topline'), and (ii) Collin McBirney, Topline's managing member. Each reporting person may be deemed to beneficially own more than 10% of the issuer's outstanding shares of Common Stock. Neurometrix Inc stock is up 101.69% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives NURO stock a score of 23 out of a possible 100.. That rank is mainly influenced by a fundamental score of 0. . Oct 15, 2020 11:00 AM EDT. Get today's NeuroMetrix stock news. You can buy and sell NeuroMetrix (NURO) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Enter Company or Symbol. NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Why NeuroMetrix's Stock is Up During Today's Session NeuroMetrix (NASDAQ: NURO) is currently up 45.17% to a price of $3.04. Revenue $7.38M. In after-market trading hours on Tuesday, NeuroMetrix Inc. (NURO) advanced 7.06% to $3.64. NURO has risen $0.38 from the previous closing price of $2.70 on volume of 682,061 shares. Description: Get the latest NeuroMetrix, Inc. (NURO) stock news and headlines to stay up to date and make informed investing and trading decisions. NeuroMetrix's stock soars in active trade after collaboration with GlaxoSmithKline on Quell Jan. 17, 2018 at 7:25 a.m. 1D 1W 1M 3M 6M 1Y 5Y. Post-Market 0.09 (2.72%) Zacks.com offers in-depth financial research with over 30years of proven results. Phone 1 781 890-9989. NeuroMetrix reports data from Quell trial for treatment of fibromyalgia; shares up 7% SA NewsWed, Jun. Fiscal Year-end 12/2021. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split. Phone 1 781 890-9989. Find real-time NURO - NeuroMetrix Inc stock quotes, company profile, news and forecasts from CNN Business. It can reflect on the current distribution of Neurometrix daily returns and investor perception about the current pice of Neurometrix as well as its diversification or hedging effects on your existing portfolios. About NURO. Press down arrow for suggestions, or Escape to return to entry field. NeuroMetrix Reports Q1 2021 Financial Results. Neurometrix Inc (NURO) stock is higher by 13.92% while the S&P 500 is lower by -0.14% as of 2:37 PM on Tuesday, Dec 22. Therapeutics. Woburn, Massachusetts 01801. GlobeNewswire. NURO: NeuroMetrix, Inc. - Earnings Announcements. NeuroMetrix — $0.00 (0.00%) Today. Sector Health Care/Life Sciences. WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test for evaluation of peripheral neuropathies such as diabetic peripheral neuropathy (DPN). NeuroMetrix Inc. (NASDAQ: NURO) stock closed at 3.12 per share at the end of the most recent trading day (a 1.63 % change compared to the prior day closing price) with a volume of 122.07K shares and market capitalization of 11.87M.Is a component of indices and it is traded on NASDAQ exchange. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. Companies Reporting Before The Bell • Republic First Bancorp (NASDAQ: FRBK ) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million. 09 1 Comment NeuroMetrix, Inc. SEC Filing - … NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Small Market Cap. Stock analysis for NeuroMetrix Inc (NURO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NeuroMetrix sold 7,000 Series E preferred shares (at a price of $1,000 per share) with warrants to purchase approximately 10 million shares of common stock. NeuroMetrix Inc. stock has also gained 3.86% of its value over the past 7 days. DPNCheck® is a point-of-care test that is used to evaluate peripheral neuropathies. View today's stock price, news and analysis for NeuroMetrix Inc. (NURO). No news for in the past two years. Over the past year the S&P 500 is higher by 50.02% while NURO is up 84.13%. As a greater than 10% beneficial owner, the Fund is separately reporting its holdings in the issuer's securities on a Form 3 filed concurrently herewith. NURO is lower by -$0.24 from the previous closing price of $3.72 on volume of 56,956 shares. Still, the Neurometrix earnings-per-share ratio is a good starting point for gauging a company's future prospects . NURO lost -$0.69 per share in the over the last 12 months. Neurometrix story: Purchase by Topline Capital Management Llc of 28238 shares of Neurometrix and other headlines for Neurometrix The Company has three FDA cleared commercial products. This price target is based on 0 analysts offering 12 month price targets for NeuroMetrix in the last 3 months. Our core expertise in biomedical engineering has been refined over two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. Get the latest Neurometrix Inc (NURO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. According to news published on Yahoo Finance, NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020.The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic health conditions. Neurometrix Inc stock is up 101.69% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives NURO stock a score of 23 out of a possible 100.. That rank is mainly influenced by a fundamental score of 0. . Get NeuroMetrix, Inc.'s stock price today. Do NOT follow this link! NeuroMetrix News: This is the News-site for the company NeuroMetrix on Markets Insider NURO's rank also includes a long-term technical score of 26. NeuroMetrix (NURO) said Monday it will secure a new patent for its Quell wearable technology on Tuesday from the US Patent and Trademark Office. News. NURO is higher by $3.55 from the previous closing price of $1.89 on volume of 9,341,946 shares. NeuroMetrix Stock News NASDAQ:NURO. On 22, October 2020, NeuroMetrix Reports Q3 2020 Financial Results. We cover the latest NeuroMetrix headlines and breaking news impacting NeuroMetrix stock performance - Page 2 NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare. NURO Stock Predictions, Articles, and Neurometrix Inc News From the Web NeuroMetrix's Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial Announces Date For Third Quarter 2020 Financial Results Conference Call. NeuroMetrix was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. We cover the latest NeuroMetrix headlines and breaking news impacting NeuroMetrix stock performance. Stay up to date with lastest Earnings Announcements for NeuroMetrix, Inc. from Zacks Investment Research NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. Neurometrix Inc. NURO Stock Message Board: Yes, Topline Capital Partners, 96.5K at $3.42. NURO Neurometrix Inc. Latest News. 10,780,269 titled “Apparatus and Method for Relieving Pain Using Transcutaneous Electrical Nerve Stimulation." Over the past six months meanwhile, it has gained 10.26% and lost -50.00% year-on date. Net Income -$2.09M. This information may help you make smarter investment decisions. NeuroMetrix. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. Investor Relations. We are a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. NeuroMetrix, Inc. Common Stock (NURO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The stock price has increased by +40.38% in the last 52 weeks. Based on an average trading volume of 1,510,000 shares, the days-to-cover ratio is currently 0.0 days. News NeuroMetrix Inc.NURO. Get the latest Neurometrix Inc (NURO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. NURO stock quote, chart and news. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X. NeuroMetrix (NASDAQ: NURO) stock is on the rise Tuesday despite a lack of news concerning the company. NeuroMetrix is a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. 1 stock was originally listed at a price of $92,736.00 in Jul 22, 2004. Neurometrix Inc (NURO) stock is lower by -6.45% while the S&P 500 is up 0.03% as of 1:47 PM on Wednesday, Apr 14. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership ... NeuroMetrix Inc is … WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. Overview Detailed Quote Charting Historical Prices. Neurometrix stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. NeuroMetrix Reports DPNCheck® Expansion in China WOBURN, Mass., July 09, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, … News NeuroMetrix Inc.NURO. Find the latest news headlines from NeuroMetrix, Inc. Common Stock (NURO) at Nasdaq.com. Quote. Get the latest news and real-time alerts from NeuroMetrix, Inc. (NURO) stock at Seeking Alpha. Neurometrix Inc. NURO Vitals Ranked in Earnings Gainer and 1 other category Data delayed 15 minutes The Company will host... NURO : 3.41 (+1.79%) NeuroMetrix Reports Q3 2020 Financial Results GlobeNewswire - Thu Oct … Sector Health Care/Life Sciences. NeuroMetrix's stock reverse split on Friday, May 12th 2017. BRIEF-NeuroMetrix Filed A Prospectus Supplement To Register The Offer And Sale Of $3.85 Million Of Co's Common Stock Reuters – 9:02 AM ET 04/15/2021 As of January 29th, there was short interest totalling 25,900 shares, a decline of 80.4% from the January 14th total of 132,300 shares. WOBURN, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2020. Neurometrix story: Purchase by Topline Capital Management Llc of 28238 shares of Neurometrix and other headlines for Neurometrix Neurometrix stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Neurometrix Inc (NURO) stock has risen 187.83% while the S&P 500 is down -1.01% as of 12:02 PM on Tuesday, Apr 14. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock… NURO has a less variance in analysts' estimates than almost 100% of all US stocks. September 21, 2020 - 1:00 pm. Get Free Stock. 1. News. Find the latest NeuroMetrix, Inc. (NURO) stock quote, history, news and other vital information to help you with your stock trading and investing. Gainers. NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. Embed . NeuroMetrix Inc's average analyst price target is greater than 86.54% of stocks in the small market cap category. The Company is engaged in the sale of medical equipment, and consumables and accessories. NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. PRESS RELEASES. NeuroMetrix, Inc. Revenue $7.38M. News & Events > Stock Details. Over the past year the S&P 500 is … NeuroMetrix, Inc. (NASDAQ:NURO) saw a significant decline in short interest in the month of January. Webull provides the latest NeuroMetrix (NURO) stock and general news. View NeuroMetrix stock trends here About NURO. The Company will host... NURO : 3.41 (+1.79%) NeuroMetrix Reports Q3 2020 Financial Results GlobeNewswire - … Get NeuroMetrix Inc (NURO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. NeuroMetrix (NASDAQ: NURO) stock is on the rise Tuesday despite a lack of news concerning the company. To go along with the increase to NURO stock, the company is seeing heavy trading of its shares. This has more than 57 million shares traded as of this writing. Get today's NeuroMetrix stock news. The company belongs in the Medical Devices & Instruments industry, Healthcare … Industry Medical Equipment/Supplies. NURO. For ETFs and Mutual Funds, return of capital and capital gains distributions are not included. View detailed financial information, real-time news, videos, quotes and analysis on NeuroMetrix, Inc. (NASDAQ:NURO). The upside potential (average analyst target price relative to current price) of NURO is higher than 99.11% of stocks in the small market cap category. WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. NeuroMetrix (NeuroMetrix: NURO) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. NeuroMetrix (NASDAQ:NURO) stock rose 7.05% to $3.64 during Tuesday’s after-market session.Today’s trading volume for this security ended … View the latest NURO stock quote and chart on MSN Money. Neurometrix Inc (NQ: NURO ) 2.920 USD-0.050 (-1.68%) Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2021 Add to My Watchlist. Farm Land For Sale In Danville, Va, What Happens If I Take Hcg And Eat Normally, 50 Euro Cent Coin Value In Pakistani Rupees, Kuttu Ka Atta Other Name, Project Ghoul Kagune Rarity, The Webdriver Photo Printing Service Snapfish Is Owned By, Wegagen Bank Mobile Banking Number, World Scout Moot 2021 Australian Contingent, Tuesday Twitch Streamer, When Tomorrow Starts Without Me Cat,

Enter Company or Symbol. The Company is … Stock analysis for NeuroMetrix Inc (NURO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Neurometrix Inc. A range of $3.355 to $3.75 was the price range of the NURO stock. Looking to buy NeuroMetrix stock? After losing roughly half of its value on Monday, when news of the AMA recommendation first surfaced, NeuroMetrix's stock tumbled another 22% to $4.20 Tuesday. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. 6 months ago - Benzinga WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. NeuroMetrix (NURO) stock is on the rise Tuesday with heavy trading despite a lack of news concerning the medical device company. Net Income … 542,240 shares of Common Stock reported in Table I on this Form 3 are beneficially owned by Topline Capital Partners, LP, Delaware limited partnership (the "Fund"). Pain Control. NURO's rank also includes a long-term technical score of 26. Overview Detailed Quote Charting Historical Prices. If you had invested in NeuroMetrix stock at $92,736.00, your return over the last 16 years would have been -100%, for an annualized return of -47.27%. The stock's volume is currently 62.04 million, which is roughly 32668.92% of its recent 30-day volume average of 189.91 thousand. WOBURN, Mass., July 09, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction. Woburn, Massachusetts 01801. No news for in the past two years. In depth view into NURO (NeuroMetrix) stock including the latest price, news, dividend history, earnings information and financials. The 1-8 reverse split was announced on Thursday, May 11th 2017. The Company is engaged in the sale of medical equipment, and consumables and accessories. Quote. The average price target represents a -100.00% upside from the last price of $4.83. NeuroMetrix Inc. NASDAQ Updated Jun 11, 2021 11:56 PM NURO 3.31 0.03 (0.90%). Find real-time NURO - NeuroMetrix Inc stock quotes, company profile, news and forecasts from CNN Business. Customizable interactive chart for Neurometrix Inc with latest real-time price quote, charts, latest news, technical analysis and opinions. All News for NURO : NeuroMetrix, Inc. - Zacks.com Press down arrow for suggestions, or Escape to return to entry field. The Company is a leader in proprietary non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Get news for Nasdaq companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public. View detailed financial information, real-time news, videos, quotes and analysis on NeuroMetrix, Inc. (NASDAQ:NURO). Stock Price Statistics. All News News Headlines Press Releases. NeuroMetrix to Secure New US Patent for Quell Wearable Technology 5:21PM ET 9/21/2020 MT Newswires. However, NURO stock has inclined by 34.38% in the 3 months of the year. NeuroMetrix Reports DPNCheck® Expansion in China. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. 2. Announces Date for Fourth Quarter and Full Year 2020 Financial Results Conference Call - GlobeNewswire globenewswire.com - … Industry Medical Equipment/Supplies. NURO Stock Price, NeuroMetrix Stock Quotes and News - Benzinga quotes.benzinga.com - January 26 at 5:23 PM: NeuroMetrix, Inc. Earnings Scheduled For April 22, 2021 08:01am, Thursday, 22'nd Apr 2021. Over the past year the S&P 500 has fallen -4.95% while NURO is down … Estimates are provided for securities with at least 5 consecutive payouts, special dividends not included. Neurometrix Inc (NQ: NURO ) 2.920 USD-0.050 (-1.68%) Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2021 Add to My Watchlist. WOBURN, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 first quarter financial results before the opening of the market on Apr... NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q4 2020 Results - Earnings Call Transcript NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. Dive deeper with interactive charts and top stories of NEUROMETRIX, INC.. ... Neurometrix Inc. U.S. News & World Report 5/19/2021. WOBURN, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office will issue on September 22, 2020 U.S. Patent No. Our core expertise in biomedical engineering has been refined over two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. Looking for stock market analysis and research with proves results? During the last trading session, NeuroMetrix stock gained 0.29% to close at $3.40. By GlobeNewswire. If the last five payouts show limited variability, we … News & Events > Stock Details. Get the stock price and latest news for NURO and start trading today with zero commissions. All News News Headlines Press Releases. The beta is 2.79, so NeuroMetrix's price volatility has been higher than the market average. Fiscal Year-end 12/2021. The reporting persons are (i) Topline Capital Management, LLC, an exempt reporting adviser ('Topline'), and (ii) Collin McBirney, Topline's managing member. Each reporting person may be deemed to beneficially own more than 10% of the issuer's outstanding shares of Common Stock. Neurometrix Inc stock is up 101.69% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives NURO stock a score of 23 out of a possible 100.. That rank is mainly influenced by a fundamental score of 0. . Oct 15, 2020 11:00 AM EDT. Get today's NeuroMetrix stock news. You can buy and sell NeuroMetrix (NURO) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Enter Company or Symbol. NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Why NeuroMetrix's Stock is Up During Today's Session NeuroMetrix (NASDAQ: NURO) is currently up 45.17% to a price of $3.04. Revenue $7.38M. In after-market trading hours on Tuesday, NeuroMetrix Inc. (NURO) advanced 7.06% to $3.64. NURO has risen $0.38 from the previous closing price of $2.70 on volume of 682,061 shares. Description: Get the latest NeuroMetrix, Inc. (NURO) stock news and headlines to stay up to date and make informed investing and trading decisions. NeuroMetrix's stock soars in active trade after collaboration with GlaxoSmithKline on Quell Jan. 17, 2018 at 7:25 a.m. 1D 1W 1M 3M 6M 1Y 5Y. Post-Market 0.09 (2.72%) Zacks.com offers in-depth financial research with over 30years of proven results. Phone 1 781 890-9989. NeuroMetrix reports data from Quell trial for treatment of fibromyalgia; shares up 7% SA NewsWed, Jun. Fiscal Year-end 12/2021. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split. Phone 1 781 890-9989. Find real-time NURO - NeuroMetrix Inc stock quotes, company profile, news and forecasts from CNN Business. It can reflect on the current distribution of Neurometrix daily returns and investor perception about the current pice of Neurometrix as well as its diversification or hedging effects on your existing portfolios. About NURO. Press down arrow for suggestions, or Escape to return to entry field. NeuroMetrix Reports Q1 2021 Financial Results. Neurometrix Inc (NURO) stock is higher by 13.92% while the S&P 500 is lower by -0.14% as of 2:37 PM on Tuesday, Dec 22. Therapeutics. Woburn, Massachusetts 01801. GlobeNewswire. NURO: NeuroMetrix, Inc. - Earnings Announcements. NeuroMetrix — $0.00 (0.00%) Today. Sector Health Care/Life Sciences. WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test for evaluation of peripheral neuropathies such as diabetic peripheral neuropathy (DPN). NeuroMetrix Inc. (NASDAQ: NURO) stock closed at 3.12 per share at the end of the most recent trading day (a 1.63 % change compared to the prior day closing price) with a volume of 122.07K shares and market capitalization of 11.87M.Is a component of indices and it is traded on NASDAQ exchange. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. Companies Reporting Before The Bell • Republic First Bancorp (NASDAQ: FRBK ) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million. 09 1 Comment NeuroMetrix, Inc. SEC Filing - … NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. Small Market Cap. Stock analysis for NeuroMetrix Inc (NURO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NeuroMetrix sold 7,000 Series E preferred shares (at a price of $1,000 per share) with warrants to purchase approximately 10 million shares of common stock. NeuroMetrix Inc. stock has also gained 3.86% of its value over the past 7 days. DPNCheck® is a point-of-care test that is used to evaluate peripheral neuropathies. View today's stock price, news and analysis for NeuroMetrix Inc. (NURO). No news for in the past two years. Over the past year the S&P 500 is higher by 50.02% while NURO is up 84.13%. As a greater than 10% beneficial owner, the Fund is separately reporting its holdings in the issuer's securities on a Form 3 filed concurrently herewith. NURO is lower by -$0.24 from the previous closing price of $3.72 on volume of 56,956 shares. Still, the Neurometrix earnings-per-share ratio is a good starting point for gauging a company's future prospects . NURO lost -$0.69 per share in the over the last 12 months. Neurometrix story: Purchase by Topline Capital Management Llc of 28238 shares of Neurometrix and other headlines for Neurometrix The Company has three FDA cleared commercial products. This price target is based on 0 analysts offering 12 month price targets for NeuroMetrix in the last 3 months. Our core expertise in biomedical engineering has been refined over two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. Get the latest Neurometrix Inc (NURO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. According to news published on Yahoo Finance, NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020.The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic health conditions. Neurometrix Inc stock is up 101.69% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives NURO stock a score of 23 out of a possible 100.. That rank is mainly influenced by a fundamental score of 0. . Get NeuroMetrix, Inc.'s stock price today. Do NOT follow this link! NeuroMetrix News: This is the News-site for the company NeuroMetrix on Markets Insider NURO's rank also includes a long-term technical score of 26. NeuroMetrix (NURO) said Monday it will secure a new patent for its Quell wearable technology on Tuesday from the US Patent and Trademark Office. News. NURO is higher by $3.55 from the previous closing price of $1.89 on volume of 9,341,946 shares. NeuroMetrix Stock News NASDAQ:NURO. On 22, October 2020, NeuroMetrix Reports Q3 2020 Financial Results. We cover the latest NeuroMetrix headlines and breaking news impacting NeuroMetrix stock performance - Page 2 NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare. NURO Stock Predictions, Articles, and Neurometrix Inc News From the Web NeuroMetrix's Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial Announces Date For Third Quarter 2020 Financial Results Conference Call. NeuroMetrix was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. We cover the latest NeuroMetrix headlines and breaking news impacting NeuroMetrix stock performance. Stay up to date with lastest Earnings Announcements for NeuroMetrix, Inc. from Zacks Investment Research NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. Neurometrix Inc. NURO Stock Message Board: Yes, Topline Capital Partners, 96.5K at $3.42. NURO Neurometrix Inc. Latest News. 10,780,269 titled “Apparatus and Method for Relieving Pain Using Transcutaneous Electrical Nerve Stimulation." Over the past six months meanwhile, it has gained 10.26% and lost -50.00% year-on date. Net Income -$2.09M. This information may help you make smarter investment decisions. NeuroMetrix. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. Investor Relations. We are a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. NeuroMetrix, Inc. Common Stock (NURO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The stock price has increased by +40.38% in the last 52 weeks. Based on an average trading volume of 1,510,000 shares, the days-to-cover ratio is currently 0.0 days. News NeuroMetrix Inc.NURO. Get the latest Neurometrix Inc (NURO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. NURO stock quote, chart and news. NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X. NeuroMetrix (NASDAQ: NURO) stock is on the rise Tuesday despite a lack of news concerning the company. NeuroMetrix is a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. 1 stock was originally listed at a price of $92,736.00 in Jul 22, 2004. Neurometrix Inc (NURO) stock is lower by -6.45% while the S&P 500 is up 0.03% as of 1:47 PM on Wednesday, Apr 14. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership ... NeuroMetrix Inc is … WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. Overview Detailed Quote Charting Historical Prices. Neurometrix stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. NeuroMetrix Reports DPNCheck® Expansion in China WOBURN, Mass., July 09, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, … News NeuroMetrix Inc.NURO. Find the latest news headlines from NeuroMetrix, Inc. Common Stock (NURO) at Nasdaq.com. Quote. Get the latest news and real-time alerts from NeuroMetrix, Inc. (NURO) stock at Seeking Alpha. Neurometrix Inc. NURO Vitals Ranked in Earnings Gainer and 1 other category Data delayed 15 minutes The Company will host... NURO : 3.41 (+1.79%) NeuroMetrix Reports Q3 2020 Financial Results GlobeNewswire - Thu Oct … Sector Health Care/Life Sciences. NeuroMetrix's stock reverse split on Friday, May 12th 2017. BRIEF-NeuroMetrix Filed A Prospectus Supplement To Register The Offer And Sale Of $3.85 Million Of Co's Common Stock Reuters – 9:02 AM ET 04/15/2021 As of January 29th, there was short interest totalling 25,900 shares, a decline of 80.4% from the January 14th total of 132,300 shares. WOBURN, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2020. Neurometrix story: Purchase by Topline Capital Management Llc of 28238 shares of Neurometrix and other headlines for Neurometrix Neurometrix stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Neurometrix Inc (NURO) stock has risen 187.83% while the S&P 500 is down -1.01% as of 12:02 PM on Tuesday, Apr 14. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock… NURO has a less variance in analysts' estimates than almost 100% of all US stocks. September 21, 2020 - 1:00 pm. Get Free Stock. 1. News. Find the latest NeuroMetrix, Inc. (NURO) stock quote, history, news and other vital information to help you with your stock trading and investing. Gainers. NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. Embed . NeuroMetrix Inc's average analyst price target is greater than 86.54% of stocks in the small market cap category. The Company is engaged in the sale of medical equipment, and consumables and accessories. NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. PRESS RELEASES. NeuroMetrix, Inc. Revenue $7.38M. News & Events > Stock Details. Over the past year the S&P 500 is … NeuroMetrix, Inc. (NASDAQ:NURO) saw a significant decline in short interest in the month of January. Webull provides the latest NeuroMetrix (NURO) stock and general news. View NeuroMetrix stock trends here About NURO. The Company will host... NURO : 3.41 (+1.79%) NeuroMetrix Reports Q3 2020 Financial Results GlobeNewswire - … Get NeuroMetrix Inc (NURO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. NeuroMetrix (NASDAQ: NURO) stock is on the rise Tuesday despite a lack of news concerning the company. To go along with the increase to NURO stock, the company is seeing heavy trading of its shares. This has more than 57 million shares traded as of this writing. Get today's NeuroMetrix stock news. The company belongs in the Medical Devices & Instruments industry, Healthcare … Industry Medical Equipment/Supplies. NURO. For ETFs and Mutual Funds, return of capital and capital gains distributions are not included. View detailed financial information, real-time news, videos, quotes and analysis on NeuroMetrix, Inc. (NASDAQ:NURO). The upside potential (average analyst target price relative to current price) of NURO is higher than 99.11% of stocks in the small market cap category. WOBURN, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2021. NeuroMetrix (NeuroMetrix: NURO) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. NeuroMetrix (NASDAQ:NURO) stock rose 7.05% to $3.64 during Tuesday’s after-market session.Today’s trading volume for this security ended … View the latest NURO stock quote and chart on MSN Money. Neurometrix Inc (NQ: NURO ) 2.920 USD-0.050 (-1.68%) Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2021 Add to My Watchlist.

Farm Land For Sale In Danville, Va, What Happens If I Take Hcg And Eat Normally, 50 Euro Cent Coin Value In Pakistani Rupees, Kuttu Ka Atta Other Name, Project Ghoul Kagune Rarity, The Webdriver Photo Printing Service Snapfish Is Owned By, Wegagen Bank Mobile Banking Number, World Scout Moot 2021 Australian Contingent, Tuesday Twitch Streamer, When Tomorrow Starts Without Me Cat,

Vill du veta mer?

Skriv ditt namn och telefonnummer så ringer vi upp dig!

Läs mer här